3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Dermatologic
1
Conditions
Breast Neoplasms
20
Neoplasms
19
Lung Neoplasms
11
Carcinoma, Non-Small-Cell Lung
8
Colorectal Neoplasms
6
Uterine Cervical Neoplasms
5
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Melanoma
5
Carcinoma, Hepatocellular
5
Brain Neoplasms
5
Skin Neoplasms
4
Ovarian Neoplasms
4
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Triple Negative Breast Neoplasms
3
Neoplasm Metastasis
3
Myeloproliferative Disorders
3
Kidney Neoplasms
3
Head and Neck Neoplasms
3
Esophageal Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Renal Cell
3
Uveal Melanoma
2
Recurrence
2
Neoplasm, Residual
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell
2
Lung Diseases
2
Glioma
2
Interventions
Specimen Handling
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Epirubicin
2
pembrolizumab
1
lenvatinib
1
enfortumab vedotin
1
anlotinib
1
amivantamab
1
Pemetrexed
1
Observation
1
Ipilimumab
1
Imatinib Mesylate
1
Glutamate Carboxypeptidase II
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
BMS-906024
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Adenoid Cystic
×
Blood Specimen Collection
×
90 days
×
Clear all
NCT01046487
2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1
Completed
26 enrolled